Cite
HARVARD Citation
Lipton, R. et al. (2018). Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective. Journal of medical economics. pp. 666-675. [Online].